We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.45
Bid: 1.20
Ask: 1.70
Change: 0.00 (0.00%)
Spread: 0.50 (41.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.45
XSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

27 Sep 2017 07:00

RNS Number : 8965R
Xeros Technology Group plc
27 September 2017
 

Xeros Technology Group plc

 

Interim results

 

Xeros Technology Group plc (AIM: XSG, 'the Group', 'Xeros'), the developer and provider of patented polymer based technologies with multiple commercial applications, today publishes its results for the six months to 30 June 2017.

 

Group highlights

 

·

Significant progress towards commercialising our technology across all targeted applications

·

Developing relationships with significant market incumbents to license technology for scale commercialisation: IP-rich, capital-light models

·

Working capital improvement through partnership with Hitachi Capital to purchase portion of existing lease portfolio and provision of ongoing lease financing in US on premise laundry

·

Group income £1.1m (2016: £0.8m). Continued investment in application portfolio and patented technologies resulting in adjusted EBITDA1 loss of £13.2m (2016: loss £7.4m). Group cash of £16.2m at 30 June 2017

 

Cleaning Technologies

 

·

Total installed estate of commercial machines increased by 36% to 378 machines (30 June 2016: 278)

·

Launch of smaller 16kg commercial washing machine well received

·

Continued internationalisation of Forward Channel Partners network providing access to new markets

·

Plan to demonstrate domestic machine prototype design at 2018 Consumer Electronics Show in January

·

Post-period end acquisition of MarKen PPE Restoration provides platform for rapid growth in high-value high-performance workwear market

·

Post-period end, first Symphony Project development agreement for trialling Xeros' technology with major global machine manufacturer

 

Tanning Technologies

 

·

First commercial tanning contract signed with leading European tannery Wollsdorf Leder - 10 year agreement to use Xeros' technology in its retanning and dyeing operations

·

Successful trial programmes continuing in four additional European tanneries with three further tanneries to commence trials in 2017.

 

Textile Technologies

 

·

Significant progress in trials to reduce water, chemistry and effluent

·

Core patent filings aiding future protection

 

1 Adjusted EBITDA is defined as loss on ordinary activities before interest, tax, share-based payment expense, non-operating exceptional costs, depreciation and amortisation

 

 

Mark Nichols, Chief Executive of Xeros, said:

 

"We have continued to make sound progress on the implementation of our strategy to establish our unique polymer technology in three world-scale industries: cleaning, tanning and textiles.

 

"We are developing IP-rich, capital-light business models to licence our technology to world-leading market incumbents that will provide Xeros with stable income streams with long term visibility.

 

"In Cleaning, we are beginning to make allies of former competitors through our Symphony Project and have developed what we believe to be a breakthrough in the design of domestic washing machines incorporating Xeros technology.

 

"In Tanning, we have signed our first commercial tanning contract with Wollsdorf - a key milestone for this business and an example of the IP-rich, capital-light model we are pursuing.

 

"In Textiles, we are also making good progress in developing our technology for use in this sector with a number of key patent applications being filed to protect our IP.

 

"We remain well positioned to deliver further progress on commercialisation across all targeted applications in the current year and into 2018."

 

 

Enquiries:

Xeros Technology Group plc

Mark Nichols, Chief Executive Officer

Paul Denney, Chief Financial Officer

Tel: 0114 321 6328

 

 

 

Jefferies International Limited (Nominated Adviser and Joint Broker)

Simon Hardy / Will Soutar

Tel: 020 7029 8000

 

 

Berenberg (Joint Broker)

Chris Bowman / Ben Wright / Amritha Murali

Tel: 020 3207 7800

 

 

Instinctif Partners

Adrian Duffield / Helen Tarbet / James Gray

 

Tel: 020 7457 2020

Notes to Editors

Xeros Technology Group plc (LN: XSG) is a platform technology company that is reinventing water intensive industrial and consumer processes by reducing water and chemistry usage with its polymer technologies. Its patented technologies have the capacity to provide material economic, operational and sustainability improvements that are unattainable with traditional processes. The Group is currently exploiting its intellectual property in three areas: Cleaning Technologies, Tanning Technologies and Textile Technologies. Xeros has a number of agreements in place with such international organisations as Hilton and Wollsdorf Leder.

 

For more information, please visit - www.xerostech.com

 

 

 

Operational review

 

Cleaning Technologies

 

The Group launched its Symphony Project in April, providing manufacturers of conventional commercial washing machines with 'open source' access to Xeros' innovative polymer technology, with a simple means of incorporating its technology at the end of their production lines. The Group then successfully demonstrated a working prototype at the Clean Show in early June.

 

Post-period end, in September, the Group signed its first Symphony Project development agreement with a leading manufacturer of commercial washing machines for technical validation and testing. Following the testing phase, the parties anticipate the commencement of commercial negotiations. In addition, discussions are ongoing with a number of other manufacturers with the overall objective of achieving broad penetration of Xeros' technology through these existing incumbents and their channels to market.

 

Under the business model being developed, Xeros and its OEM partners will share in the significant economic gains that our technology delivers. We are planning a similar approach with chemistry suppliers and discussions in this regard are also ongoing.

 

In July, the Group signed an agreement to partner with Hitachi to provide a range of lease financing packages to Xeros' commercial laundry customers and future customers across its global operations. The agreement also includes the sale of part of Xeros' existing lease portfolio.

 

Hitachi will offer Xeros' customers greater flexibility by providing a range of lease financing packages that will further enhance the attractiveness of the Group's commercial laundry proposition. Over time, the arrangement is expected to reduce the Group's working capital needs pending migration to the Symphony model.

 

In anticipation of the implementation of Symphony Project, Xeros' own presence in the market place has continued towards an indirect model whereby our own Forward Channel Partners provide lifecycle services to customers.

 

As previously stated, the Group reduced the installation and commissioning rates in Q4 2016 and Q1 2017 in order to work on improving commissioning capacity to meet demand. The Group now has 10 Forward Channel Partners who are qualified to sell, commission and service installations. We continue to see healthy demand for Xeros machines, both directly and through our Forward Channel Partners.

 

In the first six months of the year Forward Channel Partners commissioned over half of all commissioned machines. 30% of all machines commissioned were Xeros' increasingly popular 16kg machine. The demand for the latter has proved to be significant and has temporarily outstripped the Group's short term supply capacity, which is being increased so as to be able to take and deliver orders.

 

Total commercial washing machine installations and letters of agreement with a high probability of becoming binding contracts totalled 460 at 30 June 2017, (30 June 2016: 304).

 

The first of our machines supplied to our Forward Channel Partner, Richard Jay Pty in Australia, was commissioned in early September. Xeros has no physical presence in Australia. Similar arrangements are anticipated in the near term to service Dubai and Israel with all countries targeted based on water stress and cost.

 

Xeros created a new business unit, High Performance Work Wear, to serve the market for cleaning high performance protective workwear. Xeros' technology cleans and decontaminates to a level unachievable with conventional approaches whilst simultaneously extending garment life. This unit has its own leadership team to drive growth in this attractive market. The team is currently developing plans for deploying Xeros' technology both geographically and sectorally including in fire, military, transport, mining and petrochemical markets.

 

In July the Group acquired MarKen PPE Restoration to accelerate Xeros' penetration of this market and, since the acquisition, MarKen has signed new contracts worth approximately $175,000per annum.

 

In January 2018, Xeros plans to demonstrate its latest breakthrough in domestic machine design at the Consumer Electronics Show in Las Vegas. The design offers all OEMs the ability to provide their customers with washing processes which are cheaper, make their clothes and fabrics cleaner, last longer and look better. The prototype machine that will be demonstrated involves a simple and inexpensive change to conventional machines which manufacturers can include at the end of their production lines.

 

Tanning Technologies 

 

In July, the Group signed a 10-year contract with Wollsdorf Leder in Austria to progressively convert re-tanning processes to Xeros' technology.

 

In addition to the contract with Wollsdorf Leder, a further four European tanneries have completed R&D trials with Xeros and are now undertaking production scale trials. Results of which thus far have confirmed the business case assumptions. These trials are due to complete during the remainder of this year after which the Group expects a number of them to move to contract stage.

 

Since the period end, Xeros has been approached by an additional three European tanneries and trials are expected to start with these tanneries before the end of the year.

 

A full commercialistion and deployment team is being established to support the roll out of the Group's technology for Wollsdorf and future contracts.

 

Other developments

 

During the first six months of the year, the Group expanded its intellectual property portfolio with a further seven patent family applications, taking the total to 48. A number of these new patents address the application of the Group's technology in the Textiles industry. Xeros is now focussing on scaling up the results achieved in its Textiles trials to an industrial scale. Indications from workshop trials are that Xeros' technology can deliver similar levels of water, chemistry and energy savings to those already achieved in our other applications.

 

Current trading & outlook

 

In the first six months, the Group has achieved a number of key milestones in its transition from a designer and seller of polymer technology commercial washing machines towards an IP-rich, capital-light licenser of polymer-based technologies to multiple scale industries.

 

These milestones amply demonstrate the attraction of Xeros to global companies, whom we expect to become allies in commercialising and distributing our technologies in the cleaning, tanning and textile markets, to our mutual benefit.

 

We are greatly encouraged by the progress made to date in achieving large-scale commercialisation for our industry-changing technology. We look forward to making significant further progress during the rest of this year.

 

 

Financial review

 

Group earned income was generated as follows:

 

 

 

Unaudited

6 months to

 

Unaudited

6 months to

Unaudited

17 months ended

 

30 June

30 June

31 December

 

2017

2016

2016

 

£'000

£'000

£'000

Machine sales

532

509

1,540

Service income

495

271

837

Consumable sales

6

-

16

Lease interest income

43

27

73

 

_____ _

__ ____

_ _____

Total earned income

1,076

807

2,466

 

 

 

 

 

 

Group earned income increased by 33.33% to £1,076,000 in the six months ended 30 June 2017 when compared to the prior period (2016: £807,000).

 

Notably, service income from the installed base of Commercial Laundry machines has increased significantly during the six months ended 30 June 2017, showing growth of 82.6%.

 

The point at which revenue and costs from machine sales can be recognised is dependent on the completion of a number of stages. These include the installation of the machine, commissioning of the machine, acceptance of the machine by the customer, completion of utility incentive formalities, where applicable, and then, in the case of lease sales, finalisation of the lease agreement. The Group does not recognise revenue and costs from a machine sale until all of these aspects are complete.

 

The number of machines installed in the period is as follows:

 

 

 

6 months to

 

6 months to

17 months ended

 

30 June

30 June

31 December

 

2017

2016

2016

 

No.

No.

No.

Machines sold - revenue and costs taken to P&L statement

 

21

 

29

 

76

Machines commissioned and generating service revenue, but machine sale revenues and costs not yet recognised

 

90

 

15

 

64

 

 

 

 

Total Revenue generating machines

111

44

140

 

Net machines installed but not yet commissioned

 

(49)

 

72

 

70

 

Machines installed in the period

62

116

210

 

 

 

During the period the Group has focused on increasing its commissioning capacity through the use of Forward Channel Partners and this has resulted in an increase of 90 machines commissioned in the six months. The total increase in revenue generating machines was 111 machines in the six months to 30 June 2017 (30 June 2016: 44). At the start of the period the Group had 104 machines installed but not yet commissioned and, due to the focus on increasing commissioning capacity, this number was reduced to 55 at the end of the period, representing a net reduction of 49 machines during the period.

 

As at 30 June 2017 the total installed estate is 378 machines and has grown by 36% over the year (30 June 2016: 278) and by 20% in the period (31 December 2016: 316). The number of letters of agreement with a high probability of becoming binding contracts as at 30 June 2017 is 82 (30 June 2017: 26) and therefore the total installed estate and letters of agreement as at 30 June 2017 is 460 (30 June 2016: 304).

 

As at 30 June 2017 contracted future revenues amount to £4.0m (2016: £3.8m) and average contract length is 34 months (2016: 59 months).

 

Adjusted gross margin reduced to £139,000 (13% of revenue) from £160,000 (19.8% of revenue). Sales and service margins continue to be in line with expectations as the Group continues to grow its market presence in the US.

 

The Group has continued to invest in both its R&D programme and its commercialisation programme. The Group spent £2.8m on R&D including staff and patent costs (2016: £2.3m) alongside the Commercial Laundry working capital, in line with the Board's expectations. The increase in R&D costs reflects the Group's continued development of the Textiles applications and further polymer development activity. As the scope of Xeros' commercialisation activities has grown during the period headcount at 30 June 2017 increased to 134 (30 June 2016: 108). Overall, this has resulted in an Adjusted EBITDA loss of £13.2m (2016: loss £7.4m).

 

During the period Sterling has strengthened against the US$ thereby ensuring that the continuing working capital investment in the US Cleaning Technologies business is proportionally less expensive when translated into Sterling, the Group's functional currency. As at 30 June 2017 the Group had forward contracts to buy $3.5m US.

 

The Group reported a loss after tax of £15.1m (2016: loss £6.1m). The loss per share was 17.36p (2016: loss 7.18p).

 

The Group expects cash utilisation to continue to accelerate over the coming years, as we continue to fund our R&D programme alongside the roll-out in Commercial Laundry.

 

The increase in net cash outflow from operations to £13.1m (2016: £10.4m) reflects these activities and was in line with the Board's expectations.

 

The Group had existing cash resources as at 30 June 2017 of £16.2m (2016: £39.4m) and remains debt free.

 

 

 

 

Consolidated statement of profit or loss and other comprehensive income

For the six months ended 30 June 2017

 

 

Unaudited

Unaudited

Unaudited

 

 

Six months

Six months

17 months

 

 

ended

ended

ended

 

 

30 June

30 June

31 December

 

 

2017

2016

2016

 

Note

£'000

£'000

£'000

Earned income

 

1,076

807

2,466

Less: lease interest income

 

(43)

(27)

(73)

Revenue

 

1,033

780

2,393

Cost of sales

 

(937)

(647)

(2,103)

 

 

_______

_______

_______

Gross profit

 

96

133

290

Lease interest income

 

43

27

73

 

 

_______

_______

_______

Adjusted gross margin

 

139

160

363

 

 

 

 

 

Administrative expenses

 

(14,558)

(8,334)

(22,640)

 

 

 

 

 

Adjusted EBITDA*

 

(13,192)

(7,434)

(20,659)

Share-based payment expense

 

(997)

(654)

(1,232)

Non-operating exceptional costs **

 

-

-

(87)

Depreciation of tangible fixed assets

 

(273)

(113)

(372)

 

 

 

 

 

Operating loss

 

(14,462)

(8,201)

(22,350)

Finance income

 

84

1,153

1,225

Finance expense

 

(762)

-

-

 

 

_______

_______

_______

Loss before taxation

 

(15,140)

(7,048)

(21,125)

Taxation

3

-

917

886

 

 

_______

_______

_______

Loss after tax

 

(15,140)

(6,131)

(20,239)

 

 

_______

_______

_______

Other comprehensive income

 

 

 

 

Items that are or maybe reclassified to profit or loss:

 

 

 

 

Foreign currency translation differences - foreign operations

 

833

(551)

(1,720)

 

 

_______

_______

_______

Total comprehensive expense for the period

 

(14,307)

(6,682)

(21,959)

 

 

_______

_______

_______

Loss per ordinary share

 

 

 

 

Basic and diluted on loss from continuing operations

5

(17.36)p

(7.18)p

(25.04)p

 

 

_______

_______

_______

* Adjusted EBITDA comprises loss on ordinary activities before interest, tax, share-based payment expense, non-operating exceptional costs, depreciation and amortisation.

** Non-operating exceptional costs are the costs of the fundraising in November 2015.

 

Consolidated statement of changes in equity

For the six months ended 30 June 2017

 

 

 

Share

capital

Share

 premium

Merger reserve

Foreign

currency

translation

reserve

Retained

earnings

deficit

Total

 

£000

£000

£000

£000

£000

£000

 

 

 

 

 

 

 

At 1 August 2015

98

28,178

15,443

(22)

(22,426)

21,271

Loss for the period

-

-

-

-

(20,239)

(20,239)

Other comprehensive expense

-

-

-

(1,720)

-

(1,720)

Loss and total comprehensive expense for the period

-

-

-

(1,720)

(20,239)

(21,959)

Transactions with Owners recorded directly in equity:

 

 

 

 

 

 

Issue of shares

27

39,973

-

-

-

40,000

Exercise of share options

4

281

-

-

-

285

Costs of share issues

 

(2,152)

-

-

-

(2,152)

Share based payment expense

-

-

-

-

141

141

Total contributions by and distributions to owners

31

38,102

-

-

141

38,274

At 31 December 2016

129

66,280

15,443

(1,742)

(41,433)

38,677

 

 

 

 

 

 

 

At 1 January 2016

125

66,017

15,443

(93)

(27,898)

53,594

Loss for the period

-

-

-

-

(6,131)

(6,131)

Other comprehensive expense

-

-

-

(551)

-

(551)

Loss and total comprehensive expense for the period

-

-

-

(551)

(6,131)

(6,682)

Transactions with Owners recorded directly in equity:

 

 

 

 

 

 

Issue of shares

4

262

-

-

-

266

Share based payment expense

-

-

-

-

654

654

Total contributions by and distributions to owners

4

262

-

-

654

920

At 30 June 2016

129

66,279

15,443

(644)

(33,375)

47,832

 

-

-

-

 

 

 

At 1 January 2017

129

66,280

15,443

(1,742)

(41,433)

38,677

Loss for the period

-

-

-

-

(15,140)

(15,140)

Other comprehensive income

-

-

-

833

-

833

Loss and total comprehensive income for the period

-

-

-

833

(15,140)

(14,307)

Transactions with Owners recorded directly in equity:

 

 

 

 

 

 

Issue of shares

3

410

-

-

-

413

Share based payment expense

-

-

-

-

997

997

Total contributions by and distributions to owners

3

410

-

-

997

1,410

At 30 June 2017

132

66,690

15,443

(909)

(55,576)

25,780

 

Consolidated statement of financial position

As at 30 June 2017

 

Unaudited

Unaudited

Unaudited

 

30 June

30 June

31 December

 

2017

2016

2016

 

£'000

£'000

£'000

Assets

 

 

 

Non-current assets

 

 

 

Property, plant and equipment

2,375

889

1,588

Trade and other receivables

1,682

1,295

1,656

 

4,057

2,184

3,244

Current assets

 

 

 

Inventories

7,281

5,389

7,005

Derivative financial instruments

-

900

705

Trade and other receivables

1,856

1,905

1,830

Current tax asset

-

807

-

Investments - bank deposits

9,983

21,553

9,959

Cash and cash equivalents

6,220

17,870

18,975

 

25,340

48,424

38,474

 

 

 

 

Total assets

29,397

50,608

41,718

 

 

 

 

Liabilities

 

 

 

Non-current liabilities

 

 

 

Deferred tax

(39)

(22)

(39)

 

 

 

 

Current liabilities

 

 

 

Trade and other payables

(3,521)

(2,754)

(3,002)

Derivative financial instruments

(57)

-

-

 

(3,578)

(2,754)

(3,002)

 

 

 

 

Total liabilities

(3,617)

(2,776)

(3,041)

 

 

 

 

Net assets

25,780

47,832

38,677

 

Equity

 

 

 

Share capital

132

129

129

Share premium

66,690

66,279

66,280

Merger reserve

15,443

15,443

15,443

Foreign currency translation reserve

(909)

(644)

(1,742)

Accumulated losses

(55,576)

(33,375)

(41,433)

Total equity

25,780

47,832

38,677

 

 

 

 

 

Consolidated statement of cash flows

For the six months ended 30 June 2017

 

 

 

Unaudited

Unaudited

Unaudited

 

6 months to

6 months to

17 months to

 

30 June

30 June

31 December

 

2017

2016

2016

 

£000

£000

£000

Operating activities

 

 

 

Loss before tax

(15,140)

(7,048)

(21,125)

Adjustment for non-cash items:

 

 

 

Depreciation of property, plant and equipment

273

113

372

Share based payment

997

654

1,232

Increase in inventories

(1,647)

(302)

(3,957)

Increase in trade and other receivables

(171)

(1,395)

(2,424)

Increase/(decrease) in trade and other payables

1,890

(1,351)

(663)

Finance income

(84)

(1,153)

(1,225)

Finance expense

762

-

-

Cash used in operations

(13,120)

(10,482)

(27,790)

Taxes refunded

-

110

1,380

Net cash outflow used in operations

(13,120)

(10,372)

(26,410)

 

 

 

 

Investing activities

 

 

 

Finance income

85

253

520

Cash withdrawn from/(placed on) deposits with more than 3 months maturity

(24)

9,992

(8,420)

Purchases of property, plant and equipment

(69)

(271)

(811)

Net cash (outflow)/inflow from investing activities

(8)

9,974

(8,711)

 

 

 

 

Financing activities

 

 

 

Proceeds from issue of share capital, net of costs

413

266

38,133

Net cash inflow from financing activities

413

266

38,133

 

 

 

 

(Decrease)/increase in cash and cash equivalents

(12,715)

(132)

3,012

Cash and cash equivalents at start of year

18,975

17,961

15,913

Effect of exchange rate fluctuations on cash held

(40)

41

50

Cash and cash equivalents at end of the period

6,220

17,870

18,975

 

 

 

 

Notes to the financial statements

For the six months ended 30 June 2017

 

1. General information

 

The principal activity of Xeros Technology Group plc ("the Company") and its subsidiary companies (together "Xeros" or the "Group") is the development and commercialisation of patented polymer based technologies with multiple potential commercial applications.

 

Xeros Technology Group plc is domiciled in the UK and incorporated in England and Wales (registered number 8684474), and its registered office address is Unit 2 Evolution, Advanced Manufacturing Park, Whittle Way, Catcliffe, Rotherham, S60 5BL. The Company's principal activity is that of a holding company.

 

The interim financial information was approved for issue on 26 September 2017.

 

2. Basis of preparation

 

The interim financial information has been prepared under the historical cost convention and in accordance with the recognition and measurement requirements of International Financial Reporting Standards ("IFRS") as adopted by the European Union, IFRIC interpretations, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS.

 

The interim financial information has been prepared on a going concern basis and is presented in Sterling to the nearest £'000.

 

The accounting policies used in the financial information are consistent with those used in the prior year. The following adopted IFRSs have been issued but have not been applied by the Group in these financial statements. Their adoption is not expected to have a material effect on the financial statements unless otherwise indicated:

 

·

IFRS 2 Share-based Payment Amendments to clarify the classification and measurement of share-based payment transactions effective 1 January 2018

·

IFRS 9 Financial Instruments effective 1 January 2018

·

IFRS 15 Revenue from Contracts with Customers effective 1 January 2018

·

IFRS 16 Leases effective 1 January 2019

·

IFRS 17 Insurance Contracts effective 1 January 2021

·

IAS 1 Presentation of Financial Statements Amendments as result of the Disclosure initiative effective 1 January 2017

·

IAS 7 Statement of Cash Flows Amendments as result of the Disclosure initiative effective 1 January 2017

·

IAS 12 Income Taxes Amendments regarding the recognition of deferred tax assets for unrealised losses effective 1 January 2017

·

IAS 40 Investment Property Amendments to clarify transfers or property to, or from, investment property effective 1 January 2018

 

Further IFRS standards or interpretations may be issued that could apply to the Group's financial statements for the year ending 31 December 2017. If any such amendments, new standards or interpretations are issued then these may require the financial information provided in this report to be changed. The Group will continue to review its accounting policies in the light of emerging industry consensus on the practical application of IFRS.

 

The preparation of financial information in conformity with the recognition and measurement requirements of IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management's best knowledge of the amount, event or actions, actual events ultimately may differ from those estimates.

 

 

 

 

The interim financial information does not include all financial risk management information and disclosures required in annual financial statements. There have been no significant changes in any risk or risk management policies since 31 December 2016. The principal risks and uncertainties are largely unchanged and are as disclosed in the Annual Report for the 17-month period ended 31 December 2016.

 

The interim financial information for the six months ended 30 June 2017 and for the six months ended 30 June 2016 do not constitute statutory financial statements as defined in Section 434 of the Companies Act 2006 and is unaudited. The comparative figures for the 17-month period ended 31 December 2016 are not the Group's consolidated statutory accounts for that financial year. Those accounts have been reported on by the Group's auditor and delivered to the Registrar of Companies. The report of the auditor was (i) unqualified, (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under Sections 498(2) or 498(3) of the Companies Act 2006.

 

3. Taxation

 

 

Unaudited

Unaudited

Unaudited

 

6 months to

6 months to

Period ended

 

30 June

30 June

31 December

 

2017

2016

2016

 

£'000

£'000

£'000

Current tax:

 

 

 

Foreign taxes paid

-

6

20

R & D tax credits

-

(923)

(923)

Deferred tax charge

-

-

17

Total tax credit

-

(917)

(886)

 

The Group has not recognised a deferred tax asset in the consolidated statement of financial position in respect of accumulate trading losses due to the uncertainty in the timing of their crystallisation.

 

The Group accounts for Research and Development Tax Credits where there is certainty regarding HMRC approval.

 

4. Segmental analysis

 

The Group currently has one operating segment. Revenue and losses arising from that segment are the same as presented on the face of the consolidated statement of profit or loss and other comprehensive income.

 

5. Loss per share

 

Basic loss per share is calculated by dividing the loss attributable to equity holders by the weighted average number of shares in issue during the period. The Group was loss-making for the 6-month periods ended 30 June 2017 and 30 June 2016 and also for the 17-month period ended 31 December 2016. Therefore, the dilutive effect of share options has not been taken account of in the calculation of diluted earnings per share, since this would decrease the loss per share reported for each of the periods reported.

 

The calculation of basic and diluted loss per ordinary share is based on the loss for the period, as set out below.

 

 

Loss

Weighted

Loss

 

for the

average

per

 

period

number of

share

 

£'000

shares in issue

(pence)

Six months ended 30 June 2017

(15,140)

87,218,501

(17.36)p

Six months ended 30 June 2016

(6,131)

85,377,365

(7.18)p

17 months ended 31 December 2016

(20,239)

80,839,504

(25.04)p

 

The weighted average number of shares in issue throughout the period is as follows:

 

 

6 months to

6 months to

17 months to

 

30 June

30 June

31 December

 

2017

2016

2016

 

Number of

Number of

Number of

 

shares

shares

shares

Issued ordinary shares at beginning of period

86,021,911

83,403,990

65,504,879

Effect of shares issued for cash during the period

1,192,590

1,973,375

15,334,625

Weighted average number of shares for the period

87,218,501

85,377,365

80,839,504

 

6. Details of events occurring after the reporting period

 

On the 11 July 2017, the Group announced the acquisition of MarKen PPE Restoration which provides personal protection equipment cleaning, inspection and repair services from a facility in Nevada, USA. MarKen was acquired for an initial cash consideration of US$750,000 with a further contingent cash consideration of up to US$250,000, subject to certain growth targets.

 

For the year ended 30 April 2017, MarKen generated revenues of US$686,000, generating an EBITDA loss of US$72,000. As at 30 April 2017 gross assets were US$89,000. Management believe that as a result of Xeros' ownership the MarKen business will be profitable going forwards.

 

7. Seasonality

 

The Group experiences no material variations due to seasonality.

 

8. Availability of interim statement

 

This interim statement will be available on Xeros' website at www.xerostech.com.

 

Forward-looking statements

 

This announcement may include certain forward-looking statements, beliefs or opinions, including statements with respect to Xeros' business, financial condition and results of operations. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "anticipates", "targets", "aims", "continues", "expects", "intends", "hopes", "may", "will", "would", "could" or "should" or, in each case, their negative or other various or comparable terminology. These statements are made by the Xeros Directors in good faith based on the information available to them at the date of this announcement and reflect the Xeros Directors' beliefs and expectations. By their nature these statements involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. A number of factors could cause actual results and developments to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, developments in the global economy, changes in government policies, spending and procurement methodologies, and failure in health, safety or environmental policies.

 

No representation or warranty is made that any of these statements or forecasts will come to pass or that any forecast results will be achieved. Forward-looking statements speak only as at the date of this announcement and Xeros and its advisers expressly disclaim any obligations or undertaking to release any update of, or revisions to, any forward-looking statements in this announcement. No statement in the announcement is intended to be, or intended to be construed as, a profit forecast or to be interpreted to mean that earnings per Xeros share for the current or future financial years will necessarily match or exceed the historical earnings. As a result, you are cautioned not to place any undue reliance on such forward-looking statements.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFLDAAIRFID
Date   Source Headline
19th Apr 20241:13 pmRNSResult of Retail Offer
9th Apr 20242:58 pmRNSTR-1
8th Apr 20244:30 pmRNSPosting of Circular and Notice of General Meeting
8th Apr 20243:56 pmRNSTR-1
5th Apr 202410:22 amRNSTotal Voting Rights
4th Apr 20246:29 pmRNSResult of Fundraising
4th Apr 20244:49 pmRNSRetail Offer
4th Apr 20244:40 pmRNSFundraising to raise up to £5.5 million
11th Mar 20247:00 amRNSAlex Tristram joins the Board as Finance Director
8th Feb 20245:03 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSHolding(s) in Company
8th Feb 20242:51 pmRNSHolding(s) in Company
8th Feb 20249:07 amRNSHolding(s) in Company
7th Feb 20242:05 pmRNSHolding(s) in Company
6th Feb 20243:24 pmRNSHolding(s) in Company
6th Feb 202410:22 amRNSHolding(s) in Company
5th Feb 20247:00 amRNSTR-1
2nd Feb 20247:00 amRNSExercise of Warrants, Issue of Equity and TVR
29th Jan 202412:00 pmRNSHolding(s) in Company
26th Jan 20241:35 pmRNSExercise of Warrants and Total Voting Rights
19th Jan 20243:31 pmRNSExercise of warrants and Total Voting Rights
18th Jan 20242:37 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSDirector/PDMR Shareholding
17th Jan 20242:22 pmRNSHolding(s) in Company
16th Jan 20244:38 pmRNSHolding(s) in Company
15th Jan 20245:32 pmRNSHolding(s) in Company
9th Jan 20242:33 pmRNSHolding(s) in Company
8th Jan 20246:00 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSHolding(s) in Company
2nd Jan 20241:56 pmRNSBlock listing Interim Review
21st Dec 20231:38 pmRNSResults of Warrant Holder Meeting
15th Dec 202311:55 amRNSHolding(s) in Company
4th Dec 20237:00 amRNSCircular Posting & Warrant Holder Meeting Notice
29th Nov 20237:00 amRNSTerms of Warrants Consultation and Trading Update
20th Nov 20233:45 pmRNSHolding(s) in Company
14th Nov 20235:01 pmRNSHolding(s) in Company
8th Nov 20233:29 pmRNSHolding(s) in Company
3rd Nov 20233:11 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNS2023 Interim Results
18th Sep 20237:00 amRNSChange of Auditor
12th Sep 202311:17 amRNSNotice of Results and Online Presentations
4th Jul 20231:05 pmRNSSix Monthly Block Listing Review
23rd May 20231:50 pmRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
19th May 20237:00 amRNSMello2023 Investor Conference
17th May 20237:00 amRNSSecond Denim Finishing Licensing Agreement
28th Apr 20237:00 amRNSPublication of Annual Report and Notice of AGM
18th Apr 20237:00 amRNS2022 Preliminary Results
12th Apr 20235:08 pmRNSHolding(s) in Company
11th Apr 20237:00 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.